The EAGLE study is growing fast and is looking for their last 50 sites to take part in the international cluster randomised trial - could this include you? 250 sites from more than 50 countries have been randomised so far, with 1600 patients entered into the study, and over 1200 surgeons have completed the safe-anastomosis modules!

James Keatley, EAGLE Project Manager, says:

"EAGLE is one of the largest ever and most exciting studies that ESCP has ever conducted. Working as part of a global collaboration, we aim to improve outcomes for our patients and reduce anastomotic leak following right-sided bowel resection.

Any hospital in the world who performs right hemicolectomy is eligible to take part in the study. Since we began last year, we have randomised more than 250 hospitals from 51 countries to take part. These range from Spain, Italy, Greece and the United Kingdom, across to South East Asia where hospitals in Singapore, Malaysia and South Korea have already taken part in the study, to the United Arab Emirates, the Middle East and Africa where colleagues in countries such as Ethiopia, Sudan, Nigeria, Syria and Abu Dhabi have all participated so far. More recently, we've set up EAGLE networks in India and across South America where new hospitals in places such as Argentina, Brazil and Panama are taking part in the study - many of which are taking part in an ESCP study for the first time.

With amazing work from EAGLE teams across the world we've seen more than 1,600 patients entered into the study so far and more than 1,200 surgeons have completed the safe anastomosis online educational modules.

We're now in the position where we're recruiting our final 50 hospitals to take part in this ground-breaking study and we want to work with you and your hospitals and your colleagues. If your hospital has not already signed up to take part in this study.

EAGLE is just the beginning. We're growing a global network to take part in future studies, and we want to work with colleagues across the world to help inform and participate in future studies, and help us improve the care that we can provide to our patients."

Find out more and get involved by visiting the EAGLE website.